Search

Search Constraints

You searched for: Author/Creator Kitazono, Satoru

Search Results

11. Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice. Issue 4 (21st December 2020)

12. High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer. (March 2018)

13. Implementation of microsatellite instability testing for the assessment of solid tumors in clinical practice. (26th December 2022)

14. Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995–2017. (May 2019)

15. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56. (June 2020)

16. Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR. Issue 6 (2nd May 2021)

17. Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma. (19th August 2020)

18. Phase II trial of S‐1 treatment as palliative‐intent chemotherapy for previously treated advanced thymic carcinoma. (19th August 2020)

19. Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases. Issue 9 (12th July 2020)